Horizon Therapeutics Plc
(NASDAQ : HZNP)

( )
HZNP PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.59%181.440.7%$1403.21m
MRKMerck & Co., Inc. -0.81%92.520.7%$1231.41m
PFEPfizer Inc. -0.52%51.430.9%$1227.75m
LLYEli Lilly & Co. 0.06%325.901.1%$1136.77m
BMYBristol-Myers Squibb Co. -0.48%78.611.0%$1131.94m
ABBVAbbVie, Inc. -0.05%152.481.9%$1018.79m
AZNAstraZeneca Plc -0.67%66.451.0%$449.05m
SGENSeagen Inc. -1.61%176.455.7%$320.77m
GSKGSK Plc -0.60%43.430.2%$295.67m
TPTXTurning Point Therapeutics, Inc. 0.00%75.170.0%$291.93m
MRTXMirati Therapeutics, Inc. 2.70%70.001.6%$204.79m
SIGASIGA Technologies, Inc. -11.89%11.490.0%$193.57m
HZNPHorizon Therapeutics Plc 0.00%85.135.4%$182.59m
NVSNovartis AG -0.04%84.790.2%$167.69m
NVONovo Nordisk A/S 0.60%112.840.1%$148.24m

Company Profile

Horizon Therapeutics Plc is a biopharmaceutical company, which is engaged in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.